The Billion Dollar PROSTATE

Bull markets come in all shapes and sizes. This week it was the billion dollar move in $DNDN and the prostate .

A bull market in biotech won’t be the easiest to manage , because like Gold, there is no cash flow in the most exciting names. Very little is predicatable.

The biotech charts are littered with Gaps. For that reason $IBB has been my vehicle of choice.

As wealth spreads around the globe and our population ages, it makes common sense that we are in the midst of a biotech boom.

I am not sure about the rest of the markets, but the price action in the Biotechs, while wild, is trending strongly.

To get a boom going, the FDA might do well to visit the offices of Moody’s $MCO as the rating agencies sure now how to throw a market party.